Edition:
United Kingdom

People: Consun Pharmaceutical Group Ltd (1681.HK)

1681.HK on Hong Kong Stock

4.78HKD
14 Jun 2019
Change (% chg)

HK$-0.13 (-2.65%)
Prev Close
HK$4.91
Open
HK$4.90
Day's High
HK$4.92
Day's Low
HK$4.77
Volume
320,000
Avg. Vol
1,311,375
52-wk High
HK$8.15
52-wk Low
HK$4.18

Zhu, Quan 

Prof. Zhu Quan is Executive Director of Consun Pharmaceutical Group Limited. Prof. Zhu was appointed as our Director with effect from 24 December 2012. Professor ZHU is also a director and the chief scientist of GZ Consun, a director of Kangyuan and the general manager of Consun Research. Professor ZHU joined our Group in August 2006 as the chief scientist of GZ Consun. Professor ZHU is primarily responsible for the product research and development of our Group. Professor ZHU has over 30 years of experience in teaching and research at medical school and 8 years of experience in the business of pharmaceutical industry. Professor ZHU has served as professor and Ph.D. candidate supervisor at (Macau University of Science and Technology) since September 2003. He served various positions, such as a deputy director of medicine department, a director of (National Standardization Laboratory for Chinese Herbal Pharmacology), a Ph.D. candidate supervisor at (Nanjing University of Chinese Medicine) between October 1981 and November 2005. Professor ZHU also served as an expert for (Science & Technology Commission of Ministry of Education), an assessment expert for (the Life Science Department of National Natural Science Foundation) and a drug evaluation expert in Jiangsu Province and in the PRC. Professor ZHU graduated from (China Academy of Traditional Chinese Medicine) (now known as (China Academy of Chinese Medical Sciences)) in November 1981 with a master’s degree in pharmacology of traditional Chinese medicine.

Basic Compensation

Total Annual Compensation, CNY 435,000
Restricted Stock Award, CNY --
Long-Term Incentive Plans, CNY --
All Other, CNY 3,416,000
Fiscal Year Total, CNY 3,851,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Yubao An

14,401,000

Qian Li

14,340,000

Ning Tang

--

Quan Zhu

3,851,000

Lanfen Fang

--

Pei Cheng Fang

--
As Of  31 Dec 2014